Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Outlook FiscalNote Holdings Ratings and Price Targets as of March 14 2024

Elaine Mendonca by Elaine Mendonca
March 14, 2024
in Breaking News
0
Finance_Business (1)
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Analyst Outlook for FiscalNote Holdings as of March 14, 2024

In the last few months, analysts have shared a range of opinions on FiscalNote Holdings (NYSE: NOTE), including bullish, bearish, and neutral ratings. Here is a breakdown of the latest analyst actions and price targets:

Recent Analyst Ratings:
– Bullish: 3
– Indifferent: 1
– Total Ratings: 4

Changes Over Time:
– Last 30 Days: 1 Bullish
– 1 Month Ago: 2 Bullish, 1 Indifferent

12-Month Price Targets:
– Average Target: $3.50
– High Estimate: $5.00
– Low Estimate: $1.75

Key Analyst Actions:
– Michael Albanese from EF Hutton initially set a Buy rating at $5.00, later adjusting it to $5.00 from $7.00.
– Rudy Kessinger from DA Davidson upgraded the rating to Neutral at $1.75 from $0.65.
– Zach Cummings from B. Riley Securities raised the rating to Buy at $2.25 from $1.75.

Analysts continuously reassess their recommendations in response to market dynamics and company performance, adapting to recent developments involving FiscalNote Holdings.

NOTE Stock Shows Stability with Positive Price Momentum on March 14, 2024

On March 14, 2024, NOTE stock had a relatively stable performance, trading in the middle of its 52-week range and below its 200-day simple moving average. There was a slight uptick in the price of NOTE shares, with a $0.03 increase since the market last closed, representing a 1.79% rise. The stock opened at $1.71, which was $0.03 higher than its previous close. This opening price indicated a positive start to the trading day for NOTE stock, and the price momentum continued to push the stock higher throughout the day. It will be interesting to see if this positive momentum continues in the days ahead. Investors should conduct their own research and consider their individual investment goals and risk tolerance before making any decisions regarding NOTE stock or any other investment opportunity.

NOTE Stock Performance Analysis: Revenue and Net Income Increase, But Fourth Quarter Raises Concerns

On March 14, 2024, NOTE stock saw some mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year stood at $132.65 million, showing a 16.6% increase compared to the previous year. However, in the fourth quarter, total revenue dropped to $34.27 million.

Net income for NOTE was reported at -$115.46 million for the past year, which represents a 47.1% increase compared to the previous year. However, in the fourth quarter, net income decreased significantly to -$50.75 million.

Earnings per share (EPS) for NOTE stock stood at -$0.88 for the past year, showing a 76.13% increase compared to the previous year. However, in the fourth quarter, EPS dropped to -$0.39.

Overall, NOTE stock showed some positive growth in total revenue and net income compared to the previous year. However, the significant decrease in net income and EPS in the fourth quarter may have raised some concerns among investors. It will be interesting to see how the company addresses these challenges and how it impacts the stock performance in the coming months. Investors should closely monitor the company’s financial reports and announcements to make informed decisions about their investments in NOTE stock.

Tags: NOTE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Software-solutions-technology

Analyst Ratings Show Confidence in Procore Technologies

Biotechnology Stock Bull Market

Apple Acquires Canadian AI Startup DarwinAI Bolstering AI Capabilities and Innovation

Finance_Capitalization

Investors Bearish on Intuit NASDAQ INTU Options Trading

Recommended

Technology Cloud computing

Unusual Options Activity in Micron Technology A Split Sentiment Among Investors

2 years ago

Gold’s Precarious Rebound: A Temporary Respite or Bear Trap?

3 months ago
Finances-and-tech

Analyst Evaluations and Price Targets for DocGo NASDAQ DCGO

2 years ago
Upland Software Stock

Upland Software Shares Tumble Despite Strong Earnings Beat

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Trending

Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

by SiterGedge
February 8, 2026
0

Biotechnology firm Quanterix has taken a pivotal step toward transforming the diagnosis of Alzheimer's disease. The company...

Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com